SelectQuote, Inc.NYSE: SLQT

Fiscal First Quarter 2027 Earnings Presentation

· Issued by SelectQuote, Inc.

Key figures

  • Adjusted EBITDA ahead of internal forecasts and $15 million higher year-over-year
  • Revenue declined 15% year-over-year, primarily driven by IRA impacts to Healthcare Services revenue
  • On track to deliver $60 million+ in operating cash flow
  • Adjusted EBITDA of $(12) million, $9 million improvement year-over-year , reflecting prudent AEP investment
  • Adjusted EBITDA up 56% year-over-year to $11 million

On 6ix: 6ix.com/news/selectquote-fiscal-first-quarter-2027-earnings-presentation

1st Quarter Fiscal 2027

Earnings Presentation November 4, 2026

1Q Earnings Highlights

Consolidated

  • Adjusted EBITDA* ahead of internal forecasts and $15 million higher year-over-year

  • Revenue declined 15% year-over-year, primarily driven by IRA impacts to Healthcare Services revenue

  • Clear path to improved efficiency and profitability resulting from strategic investments in technology and AI

  • Strong start to AEP with heightened customer engagement and agent productivity

  • On track to deliver $60 million+ in operating cash flow

    Senior

  • Another season of elevated plan disruption fueling strong beneficiary engagement

  • Adjusted EBITDA of $(12) million, $9 million improvement year-over-year, reflecting prudent AEP investment

    Healthcare Services

  • Adjusted EBITDA up 56% year-over-year to $11 million

  • Revenue was down year-over-year, in line with expectations, primarily due to the Inflation Reduction Act

  • Profitability per SelectRx member increased 60% year-over-year

    *See "Non-GAAP Financial Measures" section on slide 2

    Well Prepared for Another Dynamic AEP

    Market Backdrop

Benefit Disruption Policy Terminations Growth Areas

While carriers are making progress toward their MA profitability targets, we anticipate another AEP of beneficiary disruption

Plan terms and benefit curtailment elevated again this year

Growth focus areas include HMOs, SNPs and Geo-specific

  • Poised for growth when opportunities present

themselves

  • Strong tenured agent mix

  • Agent-led model and technology driving robust

customer engagement to start AEP

Agile Sales Function

  • Building upon FY26's 33% recapture results

  • Re-shopping beneficiaries when appropriate

  • Building upon prior year's successful customer

engagement campaigns to help beneficiaries understand plan changes

Focus on Retention

Scalable AI Infrastructure Driving Tangible Results

Efficiency & Training

100%

of agent calls transcribed by AI for real-time coaching and post-call scorecards

Technology and AI power efficiency across the business model

  • AI handles call screening and routing

  • Real-time coaching supports agents during live calls leading to an improved beneficiary experience

    200k+

    unique calls screened through Voice AI in 1Q

  • Post-call scorecards turn conversations into training insights

    Agent Productivity

  • Voice AI streamlines Medicare enrollment

  • Automation frees up valuable agent time, accelerating productivity and overall velocity of the business

    ~20%

    reduction in Healthcare Services enrollment call time through voice AI, with higher enrollment rates

  • Human oversight stays built into the process

    Healthcare Services

  • Voice AI leads to 20% faster enrollment with higher enrollment rates

  • In-house technology powers pharmacy operations

  • Pharmacy Management System is live and shipping prescriptions, helping drive increased efficiency

Consolidated Financial Summary

Commentary

Revenue

Adjusted EBITDA*

$MM

  • Revenue reflects impact of Inflation Reduction Act as

$MM

well as prudent Senior

investment

$329

$280

  • 1Q historically an investment quarter leading into AEP and OEP selling seasons

  • Adjusted EBITDA* improved

$15 million year-over-year primarily attributable to improved Healthcare Services profitability and reduced Senior investment leading into AEP

1Q26

1Q27

$(17)

$(32)

1Q26 1Q27

*See "Non-GAAP Financial Measures" section on slide 2

Senior Financial Summary

Commentary

Revenue

$MM

Adjusted EBITDA

$MM

  • Revenue decline reflects strategically smaller agent class heading into AEP

  • Adjusted EBITDA improvement driven by continued operational efficiencies throughout the Senior sales funnel

  • Trailing-twelve-month Adjusted EBITDA of $157 million compared to the prior year period of $133 million

$59

$51

$(12)

$(21)

1Q26 1Q27 1Q26 1Q27

Healthcare Services Financial Summary

Commentary

$221

Revenue

$MM

Margin:

Adjusted EBITDA

$MM

3%

6%

  • Adjusted EBITDA margins nearly doubled, reflecting the increased operational efficiencies alongside a maturing membership base and stabilized reimbursements

  • Profitability per SelectRx member* of $108 in 1Q'27 compared to $67 in 1Q'26

  • Accelerating enrollment velocity positions SelectRx to efficiently onboard new members during AEP & OEP

$186

$11

$7

1Q26 1Q27 1Q26 1Q27

*Profitability per member is calculated as Healthcare Services divisional Adjusted EBITDA for the period divided by average members, represented by the mean of ending membership in the prior period and ending membership in the current period.

Life Financial Summary

Commentary

Revenue

$MM

Adjusted EBITDA

$MM

  • Adjusted EBITDA margins improved more than 500 bps year-over-year

  • Revenue decline reflects a decrease in Final Expense agent head count year-over-year

$47

17%

12%

$43

Margin:

$7

$6

1Q26 1Q27 1Q26 1Q27

Cash Flow Growth in FY27

Operating Cash Flow

Commentary

$MM

  • Increasing operational and cost efficiency through technology leverage

  • PBM stability maintained through multi-year contract

  • Ramping SelectRx profitability driven by the Olathe, Kansas facility

$60+

$32

$(12)

FY25A FY26A FY27E

Supplemental Information Reconciliation of Non-GAAP Measure Reconciliation of Net Loss to Adjusted EBITDA

(in thousands)

Net loss

Share-based compensation expense Transaction and severance costs Depreciation and amortization

Loss on disposal of property, equipment, and software, net Change in fair value of warrants

Interest expense, net Income tax benefit

Adjusted EBITDA

1Q FY

2027 2026

$ (20,301) $ (30,459)

2,731 4,327

3,851 185

4,460 4,300

74 -

(12,573) (15,036)

10,966 11,808

(6,216) (7,204)

$ (17,008) $ (32,079)

SelectQuote Inc.

6800 West 115th Street Suite 2511

Overland Park, Kansas 66211 Phone: (877) 678-4086

Investor Relations investorrelations@selectquote.com

13

Attention: This is an excerpt of the original content. To continue reading it, access the original document here.

SelectQuote, Inc. on 6ix

In the deck

Earlier from SelectQuote

All SelectQuote news releases